Tissue Regenix Group PLC (AIM:TRX, OTC:TSSNF) CEO Danny Lee and CFO David Cocke joined Proactive's Stephen Gunnion with details of the company's interim results, which show a strong recovery following the coronavirus (COVID-19) pandemic with revenues up 21% in constant currency.
Lee telling Proactive that Tissue also successfully completed Phase 1 of its facility expansion in the period and successfully completed development of two additional products to its portfolio.